The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026.
The contract will supply aripiprazole tablets in various package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. The contract was established through a pre-solicitation notice for an unrestricted procurement, with no set-aside designation. Xlcare Pharmaceuticals is certified as an economically disadvantaged women-owned small business and has a history of providing pharmaceuticals to federal agencies, including the VA's Consolidated Mail Outpatient Pharmacy program.
Generated 11/19/24, 9:03 AM